<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7194560\results\search\drug\results.xml">
  <result pre="nicotinamide) and other miscellaneous systemically acting drugs. Of special interest," exact="ribavirin" post="had been used in treating cases of SARS CoV."/>
  <result pre="1 anticancer and other miscellaneous systemically acting drugs. Among antivirals," exact="ribavirin" post="and telbivudine were ranked at the second and third"/>
  <result pre="and other miscellaneous systemically acting drugs. Among antivirals, ribavirin and" exact="telbivudine" post="were ranked at the second and third positions. They"/>
  <result pre="2 folds increase in the docking scores, compared with curcumin." exact="Vitamin B12" post="and nicotinamide were ranked at the 4th and 6th"/>
  <result pre="Clinical uses Chromocarb C10H6O4 190 2.08 4.03 0.92 4.80 Vasoprotective" exact="Ribavirin" post="C8H12N4O5 244 2.01 3.21 0.37 4.36 Antiviral Telbivudine C10H14N2O5"/>
  <result pre="4.80 Vasoprotective Ribavirin C8H12N4O5 244 2.01 3.21 0.37 4.36 Antiviral" exact="Telbivudine" post="C10H14N2O5 242 2.00 3.19 0.44 6.12 Hepatitis B virus"/>
  <result pre="Telbivudine C10H14N2O5 242 2.00 3.19 0.44 6.12 Hepatitis B virus" exact="Vitamin B12" post="C63H88CoN14O14P 1355 1.99 0.60 0.49 9.70 Vitamin Aminophylline C16H24N10O4"/>
  <result pre="virus Vitamin B12 C63H88CoN14O14P 1355 1.99 0.60 0.49 9.70 Vitamin" exact="Aminophylline" post="C16H24N10O4 420 1.92 4.00 0.46 3.20 Bronchodilator Nicotinamide C6H6N2O"/>
  <result pre="3.20 Bronchodilator Nicotinamide C6H6N2O 122 1.91 5.76 0.71 5.76 Vitamin" exact="Triflusal" post="C10H7F3O4 248 1.87 2.99 1.05 2.53 Cardiovascular Bemegride C8H13NO2"/>
  <result pre="Aminosalicylate Sodium C7H6NNaO3 175 1.80 4.44 0.76 1.60 Antituberculosis agents" exact="Pyrazinamide" post="C5H5N3O 123 1.80 5.42 0.52 4.29 Antituberculosis agents Temozolomide"/>
  <result pre="agents Pyrazinamide C5H5N3O 123 1.80 5.42 0.52 4.29 Antituberculosis agents" exact="Temozolomide" post="C6H6N6O2 194 1.79 3.47 0.12 3.20 Anticancer Methazolamide C5H8N4O3S2"/>
  <result pre="5.76 Glaucoma Tioxolone C7H4O3S 168 1.78 4.38 0.92 3.20 Anti-acne" exact="Propylthiouracil" post="C7H10N2OS 170 1.77 4.38 0.56 3.20 Antithyroid agent Cysteamine"/>
  <result pre="Anti-acne Propylthiouracil C7H10N2OS 170 1.77 4.38 0.56 3.20 Antithyroid agent" exact="Cysteamine" post="HCl C2H8ClNS 114 1.77 12.01 0.00 2.00 Nephropathic cystinosis"/>
  <result pre="Cysteamine HCl C2H8ClNS 114 1.77 12.01 0.00 2.00 Nephropathic cystinosis" exact="methoxamine" post="hydrochloride C11H18ClNO3 248 1.77 3.20 0.10 5.09 Alpha-adrenergic agonist"/>
  <result pre="(+,-)-Octopamine HCl C8H12ClNO2 190 1.76 4.33 0.09 5.09 Adrenergic agonist" exact="Amiloride" post="hydrochloride C6H9Cl2N7O 266 1.76 3.18 0.30 6.69 Diuretic Ribavirin"/>
  <result pre="agonist Amiloride hydrochloride C6H9Cl2N7O 266 1.76 3.18 0.30 6.69 Diuretic" exact="Ribavirin" post="is abroad spectrum antiviral agent acting by induction of"/>
  <result pre="mutations in the viral genome, especially in RNA viruses [24]." exact="Ribavirin" post="is officially approved for treating respiratory syncytial virus (RSV)"/>
  <result pre="[25]. Given the high similarity of SARS and COVID-19 Mpros," exact="ribavirin" post="might be of a value in treating COVID-19. Telbivudine"/>
  <result pre="Mpros, ribavirin might be of a value in treating COVID-19." exact="Telbivudine" post="is approved for treating hepatitis B virus [26]. The"/>
  <result pre="and best fits the viral polymerase. The high rank of" exact="telbivudine" post="in this study suggests its repurposing for COVID-19 treatment"/>
  <result pre="interactions were the driving force for binding (Fig. 2 )." exact="Ribavirin" post="formed two hydrogen bonds with the backbone of THR25"/>
  <result pre="THR25 and side chain of GLN189 (Fig. 2B and C)." exact="Telbivudine" post="formed two hydrogen bonds with SER49 and GLV189 (Fig."/>
  <result pre="into the Mpro binding site. B) The docking site of" exact="ribavirin" post="C) The ligand interactions of ribavirin with Mpro D)"/>
  <result pre="The docking site of ribavirin C) The ligand interactions of" exact="ribavirin" post="with Mpro D) The site of docking of telbivudine"/>
  <result pre="of ribavirin with Mpro D) The site of docking of" exact="telbivudine" post="E) The ligand interactions of telbivudine with Mpro. Hydrogen"/>
  <result pre="site of docking of telbivudine E) The ligand interactions of" exact="telbivudine" post="with Mpro. Hydrogen bonds are shown in purple arrows,"/>
  <result pre="17MurgueitioM.S.BermudezM.MortierJ.WolberG.In silico virtual screening approaches for anti-viral drug discoveryDrug Discov." exact="Today" post="Technol.92012(e219-e25) 18SheikhA.Al-TaherA.Al-NazawiM.Al-MubarakA.I.KandeelM.Analysis of preferred codon usage in the coronavirus"/>
  <result pre="docking studiesInterdiscip. Sci. Comput. Life Sci.82016132141 24CrottyS.MaagD.ArnoldJ.J.ZhongW.LauJ.Y.HongZ.The broad-spectrum antiviral ribonucleoside" exact="ribavirin" post="is an RNA virus mutagenNat. Med.620001375137911100123 25KorenG.KingS.KnowlesS.PhillipsE.Ribavirin in the"/>
 </snippets>
</snippetsTree>
